PVLA

Palvella Therapeutics, Inc

PVLA.US palvellatx.com + Research + Basket
CIK 0001742961
Employees 29
Phone 484 253 1461
Fiscal year end December
IPO Dec 16, 2024
Address 353 W. Lancaster Avenue, Wayne, PA, United States, 19087
149.25
-2.33 (-1.54%)
USD · NASDAQ
52-week range
71.55
161.38
Trading at 86% of the 52-week range
Market Cap
2.18B
P/E Ratio
0.00
Forward P/E
0.00
Book Value
15.07
Div. Yield
N/A
% Institutions
103.86%
% Insiders
11.21%

1 Year

+101.6%

3 Year

+713.2%

10 Year

+26.3%
Description

Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. The company's lead product candidate is QTORIN rapamycin, a novel, 3.9% anhydrous topical gel that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of angiokeratomas and other mTOR-driven skin diseases; and QTORIN pitavastatin for the treatment of disseminated superficial actinic porokeratosis. The company is based in Wayne, Pennsylvania.

Actions

Add an action for PVLA.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Wesley H. Kaupinen Founder, President, CEO & Director NA
Mr. Matthew E. Korenberg CFO, Corporate Secretary & Treasurer 1975
Ms. Kathleen Goin Chief Operating Officer 1971
Dr. Jeffrey Martini Ph.D. Chief Scientific Officer 1978
Ms. Marcy B. Nanus Vice President of Investor Relations & Corporate Affairs NA
Ms. Colleen Kelly J.D. VP & Head of Legal NA
Ms. Bohan Wei Vice President of Corporate Development & New Product Planning NA
Mr. Kent Taylor Senior Vice President of Sales NA
Ms. Sarah Foster Senior Vice President of Human Resources NA
Ms. Emily Cook Senior Vice President of Clinical Operations NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Mar 18, 2026 Kathleen Goin N/A Sale 4.30K $117.99 $507.59K SEC
Feb 27, 2026 Elaine J Heron N/A Purchase 2.40K $125.00 $300.00K SEC
Feb 27, 2026 George M Jenkins N/A Purchase 4.00K $125.00 $500.00K SEC
Jan 21, 2026 Kathleen Goin N/A Sale 4.30K $97.63 $420.00K SEC
Dec 17, 2025 Kathleen Goin N/A Sale 4.30K $96.47 $415.01K SEC
Nov 19, 2025 Kathleen Goin N/A Sale 4.30K $86.23 $370.96K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Suvretta Capital Management, LLC 1.14M Jun 30, 2026 7.88% $3.17 -1.57%
Jennison Associates LLC 960.62K Jun 30, 2026 6.67% $0.09 49.95%
BlackRock Inc 918.36K Jun 30, 2026 6.37% $0.00 33.71%
Frazier Life Sciences Management, L.P. 882.40K Jun 30, 2026 6.12% $2.94 0.00%
First Light Asset Management, LLC 771.90K Jun 30, 2026 5.36% $7.17 -21.30%
Bvf Inc 672.79K Jun 30, 2026 4.67% $2.63 -29.99%
State Street Corp 653.17K Jun 30, 2026 4.53% $0.00 42.30%
T. Rowe Price Associates, Inc. 638.87K Jun 30, 2026 4.43% $0.01 58.70%
Vanguard Capital Management, LLC 513.79K Jun 30, 2026 3.57% $0.00 7.65%
Frontier Capital Management CO Inc 478.83K Jun 30, 2026 3.32% $0.68 28.02%
Federated Hermes Inc 433.02K Jun 30, 2026 3.01% $0.10 0.00%
Woodline Partners LP 317.52K Jun 30, 2026 2.20% $0.15 0.00%
Orbimed Advisors LLC 292.36K Jun 30, 2026 2.03% $0.83 117.21%
Geode Capital Management, LLC 276.16K Jun 30, 2026 1.92% $0.00 34.32%
Siren, L.L.C. 257.49K Jun 30, 2026 1.79% $0.80 0.00%
PRIMECAP Management Company 256.18K Jun 30, 2026 1.78% $0.02 31.36%
AllianceBernstein L.P. 253.17K Jun 30, 2026 1.76% $0.01 -3.68%
Eventide Asset Management, LLC 231.48K Jun 30, 2026 1.61% $0.47 -0.76%
Emerald Advisers, LLC 229.49K Jun 30, 2026 1.59% $0.83 42.10%
FMR Inc 214.84K Jun 30, 2026 1.49% $0.00 -0.45%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 390.50K 2.71% ▲ 0.36% Sep 30, 2026
2 State Street® SPDR® S&P® Biotech ETF 364.68K 2.53% ▼ 1.87% Sep 30, 2026
3 iShares Russell 2000 ETF 308.70K 2.14% ▼ 1.15% Sep 30, 2026
4 Federated Hermes Kaufmann R 276.56K 1.92% ▲ 0.00% Jun 30, 2026
5 PGIM Jennison Small Company A 250.41K 1.74% ▲ 5.32% Sep 30, 2026
6 Eventide Healthcare & Life Sciences I 231.48K 1.61% ▲ 0.00% Jun 30, 2026
7 PRIMECAP Odyssey Aggressive Growth 208.83K 1.45% ▲ 27.74% Jun 30, 2026
8 PGIM Jennison Health Sciences Z 192.08K 1.33% ▲ 0.00% Sep 30, 2026
9 MEDICAL BioHealth EUR Acc 177.35K 1.23% ▼ 8.96% Aug 31, 2026
10 Federated Hermes Kaufmann Small Cap A 150.50K 1.04% ▲ 0.00% Jun 30, 2026

Financial Highlights

▼
Market Cap: $2.18B
Book Value: $15.07
Earnings/Share: $-4.85
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -22.06%
ROE (TTM): -46.63%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $1.88B
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 14.41M
Shares Float: 10.70M
% Insiders: 11.21%
% Institutions: 103.86%
Shares Short: 2.41M
Shares Short (Prior Month): 2.52M
Short Ratio: 9.92
Short % Float: 18.90%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-15.76M
R&D
adjust
$-22.84M
Operating Income
subtotal
$-38.60M
Other / Non-Operating Items
adjust
$-3.11M
Net Income
subtotal
$-41.72M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PVLA.US!